Researchers discover ‘weak spot’ across major COVID-19 variants
Researchers have discovered a key vulnerability across all major variants of the SARS-CoV-2 virus, including the recently emerged BA.1 and BA.2 Omicron subvariants. The weakness can be targeted by neutralizing antibodies, potentially paving the way for treatments that would be universally effective across variants.
Read Original Article: Researchers discover ‘weak spot’ across major COVID-19 variants »
